TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/26/24 21:00 | 12/20/24 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | S.d | -574 | 1.68 | 0 | -342 | -3 | 12,884 | I | ||||||||||||||||
12/6/24 21:00 | 12/4/24 | ADCT | Adc Therapeutics Sa | V8 | Health | Drug | Pharmaceutical Preparations | Redmile Group, LLC | CA | T | S.d | -52 | 2.07 | 0 | -25 | 0 | 28,612 | M | |||||||||||||||
12/6/24 21:00 | 12/4/24 | STTK | Shattuck Labs, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Redmile Group, LLC | CA | DT | S | -167 | 1.25 | 0 | -133 | -2 | 5,540 | I | |||||||||||||||
7/3/23 21:45 | 6/29/23 | IGMS | Igm Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Redmile Group, LLC | CA | D | S | -758 | 9.42 | 0 | -80 | -1 | 5,949 | I | |||||||||||||||
4/17/23 21:30 | 4/14/23 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | S.d | -1,766 | 5.84 | 0 | -302 | -2 | 12,859 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |